Shreshta Tripathi

Nephrologist. Thinking in public about kidney disease, delay, and decisions. @nsmcinternship 2024, @isn_india SoMe team

[Shreshta Tripathi @ShreshtaT]

Happy to share my *first ever* Visual Abstract!!
All thanks to my amazing mentors at @NSMCInternship!

Reference article: https://t.co/kFRUglbYxG

[Shreshta Tripathi @ShreshtaT]

🩺 Outstanding discussions on MCD, FSGS & Membranous Nephropathy today.

Anti-nephrin antibodies to Rituximab, precision nephrology is evolving rapidly

Grateful to learn from global experts👏

@isn_india @ISGDtweets @kdjhaveri @drshyambansal @koyaljainMD @jradnephro @raja_1980

[Shreshta Tripathi @ShreshtaT]

🧬 The ROADMAP era in MN is here.

MENTOR, RI-CYCLO, STARMEN & GEMRITUX trials reshaping membranous nephropathy management ⚡

B-cell targeted therapy vs traditional regimens

@isn_india @ISGDtweets @raja_1980 @drshyambansal

[Shreshta Tripathi @ShreshtaT]

🩺 “Rule of thirds” in Membranous Nephropathy:
1️⃣ Remission
2️⃣ Persistent proteinuria
3️⃣ Progression to kidney failure

Risk stratification remains key in MN management ⚡

@drshyambansal @isn_india @ISGDtweets @ISNeducation @raja_1980

[Shreshta Tripathi @ShreshtaT]

🧬 Anti-nephrin antibodies reshaping podocytopathy care.

🔹 Treatment-responsive disease
🔹 Relapses remain common
🔹 Early remission = better prognosis
🔹 RTX emerging in steroid-dependent/frequently relapsing cases ⚡

@jradnephro @ISGDtweets @isn_india @drshyambansal

[Shreshta Tripathi @ShreshtaT]

🩺 evolving evidence in adult MCNS/MCD management.

📖JASN study:
🔹 Tacrolimus + low-dose steroid: remission rates comparable to high-dose steroids
🔹 with Lower relapse rates

Potential steroid-sparing strategy with clinical relevance. ⚡

@jradnephro @isn_india @ISGDtweets

[International Society of Glomerular Disease @ISGDtweets]

Over 700 colleagues have already registered! 📌 Don’t miss our free online symposium with @isn_india: Advances in Podocytopathy. Join us live for an essential 2-hour clinical update to advance patient care.
📅 May 29
⏰ 18:30 Delhi / 14:00 London / 09:00 New York
👇 Register:
https://t.co/0TGaiJL7ia

[Shreshta Tripathi @ShreshtaT]

⚡ Resistant FSGS remains one of the biggest therapeutic challenges in nephrology.

🔹 Steroid resistance seen in 40–60%
🔹 KDIGO 2021 recommends CNIs as next-line therapy
🔹 Rituximab emerging as an important option in selected cases

@isn_india @ISGDtweets @SwatiAr76730089

[Shreshta Tripathi @ShreshtaT]

🩺 Podocytopathies in focus! ✨

Looking forward to this power-packed webinar by @isn_india & @ISGDtweets led by global experts: @drshyambansal @kdjhaveri @koyaljainMD @jradnephro @raja_1980 @SwatiAr76730089

📅 29 May 2026
⏰ 6:30 PM IST

🔗 https://t.co/W58mcrEqDk

[Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi]

Hi everyone , this is Arvind Canchi, Nephrologist in Bangalore and Everyday Cases in Nephrology #ECNeph creator.
Looking forward to learning from the All New #ECNeph

[Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi]

High Resolution Ultrasound Appearance of Medullary Sponge Kidney in Primary Distal Renal Tubular Acidosis - in @indianjnephrol
https://t.co/Q99c1nEmbL

[Shreshta Tripathi @ShreshtaT]

🚨Vascular access stenosis/thrombosis in HD pts = act EARLY

🔑 Approach:
👂Hx + exam
🩻 Duplex/venography
🎯 PTA = 1st line for symptomatic CVS
🧱 Stent if recurrent/refractory
⚡ CTO: advanced recanalization
🔪 Surgery

📚 Essentials of Interventional Nephrology @VinBhargava

[Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi]

Procalcitonin - did u know?
🔥pre-procalcitonin undergoes initial synthesis by thyroid C cells.
🔥this is transformed into procalcitonin via cleavage by endopeptidases.
🔥calcitonin, responsible for serum calcium regulation is formed following conversn by prohormone convertase.

[VR.Krishnakumar @KKNephBytes]

Post transplant TMA. Key points #transplant #KKNephBytes
@CMEINDIA1 @DrAkshayaJ @DrMedhavi_G @drshyambansal @hafeeq_benil @hardik4u24 @myadla @priti899 @ShreshtaT @suhalikapath, @arvindcanchi

[Shyam Bansal @drshyambansal]

It is nice feeling to know that one of
My article is among the most read article in transplant infectious diseases. https://t.co/xK9splKLZ4

[Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi]

Generally outpatient visits are cheaper down South. And cheapest in Kerala.

[Indian Society of Nephrology @isn_india]

It's #maymeasurementmonth
Are you aware how to measure your Blood pressure correctly
What precautions u should take for accurate results
Watch this 👇 video @ShreshtaT

[Indian Society of Nephrology @isn_india]

High BP slowly Kill Ur Kidneys
The best defense? The DASH Diet! 📉
✅ EAT MORE: Fruits, veggies, whole grains & lean proteins.
❌ LIMIT: Sodium (<1500mg) & saturated fats.
Lower your BP, protect your nephrons! 🫀💧
#DASHdiet #Hypertension #KidneyHealth #ISNIndia

[Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi]

Discussing a pt with peripheral arterial disease today on the round. What clinical test would you do - doppler or angio is the usual answer you get these days! The Ankle-Brachial Index is quite sensitive and a good test to do.
Pic courtesy: @CardioNerds Infographics

[Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi]

Study from @aiims_newdelhi
Among 1,171 kidney transplants, 79% of donors were female. Avg age of female donors was 44 yrs. In terms of the donor-recipient relationship, donating women were predominantly mothers (50.1%) & wives (35.6%).
https://t.co/XCBm4Ypgxy

[Indian Society of Nephrology @isn_india]

@isn_india is organising a webinar on Advances in Podocytopathy in collaboration with ISGD. The webinar is on 29th May, from 6.30 PM onwards IST.
Learn from experts across the world

You can register for the webinar by clicking the registration link: https://t.co/uXymEAQ7Wy